세계의 혈당 모니터링 기기 시장 규모, 점유율, 성장 분석, 제품별, 용도별, 지역별 시장 규모, 점유율, 성장 분석 - 산업 예측(2024-2031년)

Global Blood Glucose Monitoring Devices Market size was valued at USD 12.50 billion in 2022 and is poised to grow from USD 13.54 billion in 2023 to USD 23.77 billion by 2031, growing at a CAGR of 8.30% during the forecast period (2024-2031).

The blood glucose monitoring (BGM) market is experiencing notable growth driven by the increasing demand for effective diabetes management. BGM devices enable individuals with diabetes to monitor their blood glucose levels using a glucose meter, allowing them to make informed decisions about their diet, insulin dosage, and physical activity. By utilizing self-monitoring blood glucose (SMBG) technology, patients can instantly obtain accurate readings of their capillary glucose concentration, facilitating rapid diagnosis of conditions such as hypoglycemia and hyperglycemia. This technological advancement not only enhances patient empowerment and self-care but also encourages healthier lifestyle choices. With a diverse range of glucose meters available in various shapes, sizes, and price points, there is a growing awareness of the importance of diabetes management solutions. This increasing consumer awareness is expected to fuel significant market opportunities, especially in underserved areas where diabetes monitoring devices are least accessible. The market for self-monitoring blood glucose devices in the U.S. is projected to achieve sustainable growth, driven by the ongoing demand for better glycemic control and innovative management solutions. As the prevalence of diabetes continues to rise, the BGM market strategically positions itself for expansion, supported by the integration of advanced technology and a deeper understanding of patient needs in diabetes care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Glucose Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Glucose Monitoring Devices Market Segmental Analysis

Global Blood Glucose Monitoring Devices Market is segmented by Product, Application, and region. Based on Product, the market is segmented into Blood Glucose Monitors, Glucose Monitoring Strips, and Lancets. Based on Application, the market is segmented into Hospitals and Clinics, Diagnostic Centers, and Home Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Blood Glucose Monitoring Devices Market

The global Blood Glucose Monitoring Devices market is significantly driven by the alarming rise in diabetes prevalence, particularly among the aging population susceptible to the disease. With an estimated 537 million adults diagnosed globally, as reported by the International Diabetes Federation, countries like China, India, the United States, Brazil, and Mexico represent a staggering 51.6% of this demographic. Contributing factors such as rapid urbanization and increasingly sedentary lifestyles further exacerbate this public health concern. Additionally, heightened awareness about diabetes management and preventive care, along with continuous innovations in monitoring technology, is propelling market growth and driving the adoption of these essential devices.

Restraints in the Global Blood Glucose Monitoring Devices Market

The global blood glucose monitoring devices market faces significant restraints from the high costs associated with these devices and the inadequacy of reimbursements. In developing nations like China and India, the burden of purchasing blood glucose monitors and test strips falls solely on patients, leading to limited accessibility and affordability. In contrast, developed countries such as Canada and certain European nations impose restrictions on the number of annually provided test strips based on specific treatment plans, discouraging comprehensive monitoring for many patients. This situation ultimately curtails market growth, as patients often forego necessary monitoring due to financial constraints.

Market Trends of the Global Blood Glucose Monitoring Devices Market

The Global Blood Glucose Monitoring Devices market is experiencing significant growth driven by technological advancements and innovative solutions aimed at improving patient care. As medical device companies shift from traditional manufacturing to becoming problem solvers, the integration of cloud computing and the Internet of Things (IoT) is revolutionizing diabetes management. Cutting-edge devices, including non-invasive monitoring solutions utilizing radio frequency and multi-sensor technology, as well as optical methods for glucose measurement, enhance accuracy and user-friendliness. This trend towards more sophisticated and connected devices not only caters to the rising prevalence of diabetes but also supports real-time remote monitoring, thereby enhancing clinical outcomes and reducing healthcare costs.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Trade Analysis
• Supply chain Analysis
• Case study Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Blood Glucose Monitoring Devices Market by Product

• Market Overview
• Blood Glucose Monitors
  • Single Point Blood Glucose Meters
  • Continuous Glucose Monitoring Systems
  • Sensors
  • Transmitter and Receivers
  • External Monitor
• Glucose Monitoring Strips
• Lancets

Blood Glucose Monitoring Devices Market by Application

• Market Overview
• Hospitals and Clinics
• Diagnostic Centers
• Home Settings

Blood Glucose Monitoring Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Abbott (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holdings (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glysens Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AgaMatrix, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trividia Health, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MediWise Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaMonTech AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinocare, Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini Diagnostics (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beurer GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prodigy Diabetes Care, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omron Healthcare, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments